Development of a two-dimensional liquid chromatography/mass spectrometry workflow for characterization of phosphorodiamidate morpholino oligomers

被引:0
作者
Wei, Tao [1 ]
Wang, Mingming [1 ]
Cai, Bao Zhong [1 ]
机构
[1] Sarepta Therapeut Inc, Proc Dev, Cambridge, MA 02142 USA
关键词
Two-dimensional liquid chromatography/mass spectrometry (2D-LC/MS); Strong cation exchange chromatography (SCX); Hydrophilic interaction chromatography (HILIC); Phosphorodiamidate morpholino oligomer (PMO); Impurity profiling; HYDROPHILIC-INTERACTION CHROMATOGRAPHY; MASS-SPECTROMETRY; ANTISENSE OLIGOMERS; INHIBITION; SEPARATION; VIRUS; MODULATION; RESISTANCE; DISCOVERY;
D O I
10.1016/j.chroma.2025.466129
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive two-dimensional liquid chromatography/mass spectrometry (2D-LC/MS) workflow was developed for characterization of phosphorodiamidate morpholino oligomers (PMOs) for the first time. This workflow employed strong cation exchange chromatography (SCX) as the first dimension (1D), and hydrophilic interaction chromatography (HILIC) as the second dimension (2D), with ammonium formate as MS-compatible salt in both dimensions. Peaks of interest were collected using multiple heart cutting (MHC) and transferred to 2D HILIC for online desalting and orthogonal separation prior to high resolution MS (HR-MS) analysis for impurity identification. Active solvent modulation (ASM) was utilized to address the elution strength incompatibility between 1D SCX and 2D HILIC, allowing for improved peak shape leading to enhanced resolution, and increased peak capacity by the 2D-LC approach. This workflow was initially demonstrated by analyzing a 30-mer PMO spiked with n-1 deletion impurity markers and was subsequently applied to effectively elucidate the impurity profiles of three PMO drug substances (ranging from 22-mer to 30-mer), affording identification of impurities at low levels. The impurity profiles suggested common impurity classes were formed in the PMOs, despite varying lengths or sequences, and were structurally related to their parent PMOs. This 2D-LC/MS workflow improves PMO impurity characterization by increasing peak capacity, providing high MS sensitivity, and enabling streamlined impurity analysis with short data turnaround time.
引用
收藏
页数:12
相关论文
共 54 条
[1]   HYDROPHILIC-INTERACTION CHROMATOGRAPHY FOR THE SEPARATION OF PEPTIDES, NUCLEIC-ACIDS AND OTHER POLAR COMPOUNDS [J].
ALPERT, AJ .
JOURNAL OF CHROMATOGRAPHY, 1990, 499 :177-196
[2]   Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides [J].
Alpert, Andrew J. .
ANALYTICAL CHEMISTRY, 2008, 80 (01) :62-76
[3]   Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models [J].
Burrer, Renaud ;
Neuman, Benjamin W. ;
Ting, Joey P. C. ;
Stein, David A. ;
Moulton, Hong M. ;
Iversen, Patrick L. ;
Kuhn, Peter ;
Buchmeier, Michael J. .
JOURNAL OF VIROLOGY, 2007, 81 (11) :5637-5648
[4]   Impurities in Oligonucleotide Drug Substances and Drug Products [J].
Capaldi, Daniel ;
Teasdale, Andy ;
Henry, Scott ;
Akhtar, Nadim ;
den Besten, Cathaline ;
Gao-Sheridan, Samantha ;
Kretschmer, Matthias ;
Sharpe, Neal ;
Andrews, Ben ;
Burm, Brigitte ;
Foy, Jeffrey .
NUCLEIC ACID THERAPEUTICS, 2017, 27 (06) :309-322
[5]   Strategies to circumvent the solvent strength mismatch problem in online comprehensive two-dimensional liquid chromatography [J].
Chapel, Soraya ;
Heinisch, Sabine .
JOURNAL OF SEPARATION SCIENCE, 2022, 45 (01) :7-26
[6]   In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus [J].
Deas, Tia S. ;
Bennett, Corey J. ;
Jones, Susan A. ;
Tilgner, Mark ;
Ren, Ping ;
Behr, Melissa J. ;
Stein, David A. ;
Iversen, Patrick L. ;
Kramer, Laura D. ;
Bernard, Kristen A. ;
Shi, Pei-Yong .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2470-2482
[7]   Method development for HILIC assays [J].
Dejaegher, Bieke ;
Mangelings, Debby ;
Heyden, Yvan Vander .
JOURNAL OF SEPARATION SCIENCE, 2008, 31 (09) :1438-1448
[8]   Chemistry, structure and function of approved oligonucleotide therapeutics [J].
Egli, Martin ;
Manoharan, Muthiah .
NUCLEIC ACIDS RESEARCH, 2023, 51 (06) :2529-2573
[9]   Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers [J].
Ge, Qing ;
Pastey, Manoj ;
Kobasa, Darwyn ;
Puthavathana, Piliapan ;
Lupfer, Christopher ;
Bestwick, Richard K. ;
Iversen, Patrick L. ;
Chen, Jianzhu ;
Stein, David A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) :3724-3733
[10]   Impact of nucleotide hydrophobicity on oligonucleotides separation in liquid chromatography [J].
Gilar, Martin ;
Schomann, Nils ;
Schott, Saskia ;
Ruehl, Michael .
JOURNAL OF CHROMATOGRAPHY A, 2025, 1753